Treatment of Severe Alcoholic Hepatitis

被引:56
作者
Thursz, Mark [1 ]
Morgan, Timothy R. [2 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Div Digest Dis, St Marys Hosp Campus,Norfolk Pl, London W2 1NY, England
[2] VA Long Beach Healthcare Syst, VA Long Beach Healthcare, Gastroenterol Serv, Long Beach, CA USA
基金
美国国家卫生研究院;
关键词
NAC; Alcoholism; Cirrhosis; Steroid; SHORT-TERM SURVIVAL; NECROSIS-FACTOR-ALPHA; DOUBLE-BLIND; CONTROLLED-TRIAL; ENTERAL NUTRITION; LIVER-DISEASE; CORTICOSTEROID-THERAPY; PARENTERAL-NUTRITION; RANDOMIZED-TRIAL; N-ACETYLCYSTEINE;
D O I
10.1053/j.gastro.2016.02.074
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Alcoholic hepatitis (AH) is a syndrome of jaundice and liver failure that occurs in a minority of heavy consumers of alcohol. The diagnosis usually is based on a history of heavy alcohol use, findings from blood tests, and exclusion of other liver diseases by blood and imaging analyses. Liver biopsy specimens, usually collected via the transjugular route, should be analyzed to confirm a diagnosis of AH in patients with an atypical history or presentation. The optimal treatment for patients with severe AH is prednisolone, possibly in combination with N-acetyl cysteine. At present, only short-term increases in survival can be expected-no treatment has been found to increase patient survival beyond 3 months. Abstinence is essential for long-term survival. New treatment options, including liver transplantation, are being tested in trials and results eagerly are awaited.
引用
收藏
页码:1823 / 1834
页数:12
相关论文
共 75 条
[1]
Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study [J].
Addolorato, Giovanni ;
Leggio, Lorenzo ;
Ferrulli, Anna ;
Cardone, Silvia ;
Vonghia, Luisa ;
Mirijello, Antonio ;
Abenavoli, Ludovico ;
D'Angelo, Cristina ;
Caputo, Fabio ;
Zambon, Antonella ;
Haber, Paul S. ;
Gasbarrini, Giovanni .
LANCET, 2007, 370 (9603) :1915-1922
[2]
Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial [J].
Akriviadis, E ;
Botla, R ;
Briggs, W ;
Han, S ;
Reynolds, T ;
Shakil, O .
GASTROENTEROLOGY, 2000, 119 (06) :1637-1648
[3]
FAILURE OF COLCHICINE TO IMPROVE SHORT-TERM SURVIVAL IN PATIENTS WITH ALCOHOLIC HEPATITIS [J].
AKRIVIADIS, EA ;
STEINDEL, H ;
PINTO, PC ;
FONG, TL ;
KANEL, G ;
REYNOLDS, TB ;
GUPTA, S .
GASTROENTEROLOGY, 1990, 99 (03) :811-818
[4]
Combining steroids with enteral nutrition:: a better therapeutic strategy for severe alcoholic hepatitis?: Results of a pilot study [J].
Alvarez, MA ;
Cabré, E ;
Lorenzo-Zuñiga, V ;
Montoliu, S ;
Planas, R ;
Gassull, MA .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (12) :1375-1380
[5]
The tumor necrosis factor ligand and receptor families [J].
Bazzoni, F ;
Beutler, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (26) :1717-1725
[6]
Randomised controlled double-blind trial of the calcium channel antagonist amlodipine in the treatment of acute alcoholic hepatitis [J].
Bird, GLA ;
Prach, AT ;
McMahon, AD ;
Forrest, JAH ;
Mills, PR ;
Danesh, BJ .
JOURNAL OF HEPATOLOGY, 1998, 28 (02) :194-198
[7]
A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic Hepatitis [J].
Boetticher, Nicholas C. ;
Peine, Craig J. ;
Kwo, Paul ;
Abrams, Gary A. ;
Pateo, Tushar ;
Aqel, Bashar ;
Boardman, Lisa ;
Gores, Gregory J. ;
Harmsen, William S. ;
McClain, Craig J. ;
Kamath, Patrick S. ;
Shah, Vijay H. .
GASTROENTEROLOGY, 2008, 135 (06) :1953-1960
[8]
BONKOVSKY HL, 1991, AM J GASTROENTEROL, V86, P1200
[9]
Alcoholic liver disease [J].
Bruha, Radan ;
Dvorak, Karel ;
Petrtyl, Jaromir .
WORLD JOURNAL OF HEPATOLOGY, 2012, 4 (03) :81-90
[10]
NUTRITIONAL-STATUS OF ALCOHOLIC PATIENTS - ITS POSSIBLE RELATIONSHIP TO ALCOHOLIC LIVER-DAMAGE [J].
BUNOUT, D ;
GATTAS, V ;
ITURRIAGA, H ;
PEREZ, C ;
PEREDA, T ;
UGARTE, G .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1983, 38 (03) :469-473